🇺🇸 FDA
Pipeline program

pantoprazole 20 mg (drug)

BY1023/NL503

Phase 3 small_molecule active

Quick answer

pantoprazole 20 mg (drug) for Chronic Use of Acid Suppressive Medication is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Use of Acid Suppressive Medication
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials